BackAytu BioPharma Overview

Aytu BioPharma Intangible Assets

Track Aytu BioPharma's intangible assets ($41M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$41.40M
↓ 1.89% YoYΔ $-798000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Aytu BioPharma Intangible Assets History

Loading

Aytu BioPharma vs. peers: Intangible Assets Comparison

Loading

Aytu BioPharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aytu BioPharma (AYTU) FAQ

The latest intangible assets for AYTU is $41M as of June 2026. That compares with $42M in the prior-year period — down 1.9% year over year. Investors often review this figure alongside Aytu BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, AYTU's intangible assets moved from $42M to $41M — a 1.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aytu BioPharma's operating scale or balance-sheet position.

A intangible assets figure of $41M for AYTU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AYTU's intangible assets ($41M), review year-over-year change from $42M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aytu BioPharma's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.